Quality attributes of recombinant therapeutic proteins: an assessment of impact on safety and efficacy as part of a quality by design development approach
- PMID: 22473974
- DOI: 10.1002/btpr.1548
Quality attributes of recombinant therapeutic proteins: an assessment of impact on safety and efficacy as part of a quality by design development approach
Abstract
Quality by Design (QbD) is a new approach to the development of recombinant therapeutic protein products that promotes a better understanding of the product and its manufacturing process. The first step in the QbD approach consists in identifying the critical quality attributes (CQA), i.e., those quality attributes of the product that have an impact on its clinical efficacy or safety. CQAs are identified through a science-based risk assessment taking into consideration a combination of clinical and nonclinical data obtained with the molecule or other similar molecules or platform products, as well as the published literature. The purpose of this article is to perform a comprehensive review of the published literature, supporting an assessment of the impact on safety and efficacy of the quality attributes commonly encountered in recombinant therapeutic proteins, more specifically those produced in mammalian cell expression systems. Quality attributes generally observed in biopharmaceutical proteins including product-related impurities and substances, process-related impurities, product attributes, and contaminants are evaluated one by one for their impact on biological activity, pharmacokinetics and pharmacodynamics, immunogenicity, and overall safety/toxicity.
Copyright © 2012 American Institute of Chemical Engineers (AIChE).
Similar articles
-
Roadmap for implementation of quality by design (QbD) for biotechnology products.Trends Biotechnol. 2009 Sep;27(9):546-53. doi: 10.1016/j.tibtech.2009.06.006. Epub 2009 Aug 3. Trends Biotechnol. 2009. PMID: 19647883 Review.
-
[The Identification of Critical Quality Attributes (CQAs) for the Development of Antibody Drugs].Yakugaku Zasshi. 2018;138(12):1475-1481. doi: 10.1248/yakushi.18-00020-1. Yakugaku Zasshi. 2018. PMID: 30504661 Review. Japanese.
-
Application of quality by design principles to the development and technology transfer of a major process improvement for the manufacture of a recombinant protein.Biotechnol Prog. 2011 Nov-Dec;27(6):1718-29. doi: 10.1002/btpr.672. Epub 2011 Sep 21. Biotechnol Prog. 2011. PMID: 21948302
-
Overview of the nonclinical quality and toxicology testing for recombinant biopharmaceuticals produced in mammalian cells.J Appl Toxicol. 2010 Jul;30(5):387-96. doi: 10.1002/jat.1551. J Appl Toxicol. 2010. PMID: 20589744 Review.
-
High-throughput process development for biopharmaceutical drug substances.Trends Biotechnol. 2011 Mar;29(3):127-35. doi: 10.1016/j.tibtech.2010.12.001. Epub 2011 Jan 20. Trends Biotechnol. 2011. PMID: 21255855 Review.
Cited by
-
Enhancing chemical and physical stability of pharmaceuticals using freeze-thaw method: challenges and opportunities for process optimization through quality by design approach.J Biol Eng. 2023 May 23;17(1):35. doi: 10.1186/s13036-023-00353-9. J Biol Eng. 2023. PMID: 37221599 Free PMC article. Review.
-
Main Quality Attributes of Monoclonal Antibodies and Effect of Cell Culture Components.Iran Biomed J. 2017 May;21(3):131-41. doi: 10.18869/acadpub.ibj.21.3.131. Epub 2017 Apr 20. Iran Biomed J. 2017. PMID: 28176518 Free PMC article. Review.
-
Correlated analytical and functional evaluation of higher order structure perturbations from oxidation of NISTmAb.MAbs. 2023 Jan-Dec;15(1):2160227. doi: 10.1080/19420862.2022.2160227. MAbs. 2023. PMID: 36683157 Free PMC article.
-
The Fluorescent Enzyme Cascade Detects Low Abundance Protein Modifications Suitable for the Assembly of Functionally Annotated Modificatome Databases.Chembiochem. 2022 Oct 6;23(19):e202200399. doi: 10.1002/cbic.202200399. Epub 2022 Aug 23. Chembiochem. 2022. PMID: 35920326 Free PMC article.
-
Dissecting N-Glycosylation Dynamics in Chinese Hamster Ovary Cells Fed-batch Cultures using Time Course Omics Analyses.iScience. 2019 Feb 22;12:102-120. doi: 10.1016/j.isci.2019.01.006. Epub 2019 Jan 7. iScience. 2019. PMID: 30682623 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources